Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India Plans Half Billion-Dollar Investment In Neglected-Disease Drugs

This article was originally published in PharmAsia News

Executive Summary

India's government plans to invest $483.4 million into research and development of innovative drugs to spur development of treatments for neglected diseases. The program is said to be one of the biggest R&D initiatives in the drug industry. The government investment, however, relies on private industry to match its investment. In all, the Indian government plans to accumulate $1 billion over the next five years to use in promoting innovative drugs, half of the funds restricted to the domestic industry. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071099

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel